6533b85efe1ef96bd12bf520
RESEARCH PRODUCT
Modulation of central corneal thickness by various riboflavin eyedrop compositions in porcine corneas
Marija Tubic-grozdanisSabine KurzStephan BruecknerNorbert PfeifferJan M. VetterUrs Voßmerbäumersubject
medicine.medical_specialtySwineRiboflavinRiboflavinCorneaCorneal edemaCorneaOphthalmologyIsotonicAnimalsMedicineBody Weights and MeasuresUltrasonographyPhotosensitizing Agentsbusiness.industryCorneal EdemaOsmolar ConcentrationUltrasound pachymetryHydrogen-Ion ConcentrationSensory SystemsSurgeryOphthalmologyCross-Linking ReagentsOphthalmic solutionsmedicine.anatomical_structurePhotochemotherapySurgeryOphthalmic Solutionsbusinessdescription
Purpose To evaluate the modulatory effect of various riboflavin 0.1% and 0.2% compositions on the central corneal thickness (CCT) in fresh porcine corneas. Setting Department of Ophthalmology, Johannes Gutenberg University of Mainz, Mainz, Germany. Design Experimental study. Methods The CCT in freshly enucleated porcine globes was measured by ultrasound pachymetry before and after (if applicable) deepithelialization and every 10 minutes thereafter during 120 minutes of eyedrop application. In Groups 1 and 2 (controls), no eyedrops were applied. In Groups 3 and 4, isotonic riboflavin eyedrops were used. In Groups 5 to 9, hypotonic riboflavin eyedrops were given. In Groups 10 and 11, preparations for transepithelial crosslinking were applied. In Groups 2 to 9, deepithelialization was performed. The final CCT in the groups was compared by analysis of variance. Results One hundred ten freshly enucleated porcine globes were used. The mean final CCT compared with preoperative values was 97% ± 4% (SD) in Group 1, 91% ± 4% in Group 2, 66% ± 5% in Group 3, 151% ± 13% in Group 4, 65% ± 2% in Group 5, 105% ± 3% in Group 6, 120% ± 4% in Group 7, 130% ± 4% in Group 8, 132% ± 4% in Group 9, 114% ± 2% in Group 10, and 114% ± 4% in Group 11. The differences between Group 1 and each of Groups 3, 4, 5, 7, 8, and 9 were statistically significant (P Conclusion There was considerable variation in the final CCT as a result of varying riboflavin eyedrop compositions. Financial Disclosure No author has a financial or proprietary interest in any material or method mentioned.
year | journal | country | edition | language |
---|---|---|---|---|
2012-03-01 | Journal of Cataract and Refractive Surgery |